SEC v. Giguiere

Giguiere allegedly engaged in fraudulent schemes involving two separate microcap issuers he controlled on an undisclosed basis. Giguiere allegedly caused the first issuer, a purported technology company focused on the cannabis industry, to improperly issue stock to his nominee entity, and then liquidated that stock while concurrently promoting it, earning several million dollars in illicit proceeds. According to the complaint, Giguiere also used his undisclosed control of the second issuer, a purported medical device company, to profit by conducting a matched trading scheme in the stock.

Summary generated from official Securities and Exchange Commission press release